Clinical characteristics of potential kidney donors with asymptomatic kidney stones

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2695-2700

  Lorenz, Elizabeth C ^a   Lieske, John C ^a   Vrtiska, Terri J ^a   Krambeck, Amy E ^a   Li, Xujian ^a   Bergstralh, Eric J ^a   Melton, L Joseph ^a   Rule, Andrew D ^a  

^a MAYO CLINIC   (United States)

Author keywords

chronic kidney disease; kidney anatomy; kidney stone; nephrolithiasis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASYMPTOMATIC DISEASE; CAUCASIAN; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHIC UROGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERTENSION; HYPERURICEMIA; HYPOPHOSPHATEMIA; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY SCAR; MAJOR CLINICAL STUDY; MALE; MEDULLARY SPONGE KIDNEY; METABOLIC SYNDROME X; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; RENOGRAPHY; SEX DIFFERENCE; STONE COUNT; STONE DIAMETER; URINE VOLUME; UROGENITAL SYSTEM PARAMETERS; UROGRAPHY;

ADOLESCENT; ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; KIDNEY CALCULI; KIDNEY FAILURE, CHRONIC; LIVING DONORS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79961078791     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq769     Document Type: Article

References (34)

1. Stamatelou KK, Francis ME, Jones CA et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-1823 (Pubitemid 36513328)
2. Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol 2009;4:680-684
3. Johnson CM, Wilson DM, O'Fallon WM et al. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 1979;16:624-631 (Pubitemid 10163674)
4. Soucie JM, Coates RJ, McClellan W et al. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 1996;143:487-495 (Pubitemid 26085079)
5. D'Angelo A, Calo L, Cantaro S et al. Calciotropic hormones and nephrolithiasis. Miner Electrolyte Metab 1997;23:269-272 (Pubitemid 27475359)
6. Parks J, Coe F, Favus M. Hyperparathyroidism in nephrolithiasis. Arch Intern Med 1980;140:1479-1481 (Pubitemid 10024962)
7. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005;68:1230-1235 (Pubitemid 43246441)
8. Curhan GC, Willett WC, Rimm EB et al. Body size and risk of kidney stones. J Am Soc Nephrol 1998;9:1645-1652 (Pubitemid 28405072)
9. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005;293:455-462
10. Abate N, Chandalia M, Cabo-Chan AV Jr. et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65:386-392 (Pubitemid 38130632)
11. Maalouf NM, Cameron MA, Moe OW et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007;2:883-888
12. West B, Luke A, Durazo-Arvizu RA et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 2008;51:741-747 (Pubitemid 351626247)
13. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ 1990;300:1234-1236 (Pubitemid 20170675)
14. Madore F, Stampfer MJ, Rimm EB et al. Nephrolithiasis and risk of hypertension. Am J Hypertens 1998;11:46-53 (Pubitemid 28083151)
15. Madore F, Stampfer MJ, Willett WC et al. Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 1998;32:802-807 (Pubitemid 28516311)
16. Sinha MK, Collazo-Clavell ML, Rule A et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007;72:100-7 (Pubitemid 47014438)
17. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 2005;67:685-690 (Pubitemid 40139861)
18. Jungers P, Joly D, Barbey F et al. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 2004;44:799-805 (Pubitemid 39445911)
19. Rule AD, Bergstralh EJ, Melton LJ 3rd et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009;4:804-811
20. Vupputuri S, Soucie JM, McClellan W et al. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 2004;14:222-228 (Pubitemid 38249337)
21. Worcester EM, Parks JH, Evan AP et al. Renal function in patients with nephrolithiasis. J Urol 2006;176:600-603; discussion 3. (Pubitemid 43927885)
22. Torres VE, Wilson DM, Hattery RR et al. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993;22:513-519 (Pubitemid 23308959)
23. Varanelli MJ, Coll DM, Levine JA et al. Relationship between duration of pain and secondary signs of obstruction of the urinary tract on unenhanced helical CT. AJR Am J Roentgenol 2001;177:325-330 (Pubitemid 32660487)
24. Parks JH, Coe FL, Strauss AL. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med 1982;306:1088-1091 (Pubitemid 12111438)
25. Yagisawa T, Kobayashi C, Hayashi T et al. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis 2001;37:1140-1143 (Pubitemid 32525148)
26. Lorenz EC, Vrtiska TJ, Lieske JC et al. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol 2010;5:431-438
27. Melton LJ 3rd. The threat to medical-records research. N Engl J Med 1997;337:1466-1470
28. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80
29. Saucier NA, Sinha MK, Liang KV et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 2009;55:61-68
30. Tsao KC, Wu TL, Chang PY et al. Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 2007;21:426-431
31. Parks JH, Coe FL, Evan AP et al. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 2009;103:670-678
32. Younes NA, Shafagoj Y, Khatib F et al. Laboratory screening for hyperparathyroidism. Clin Chim Acta 2005;353:1-12 (Pubitemid 40215428)
33. Prie D, Huart V, Bakouh N et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002;347:983-991
34. Taylor EN, Curhan GC. Diet and fluid prescription in stone disease. Kidney Int 2006;70:835-839 (Pubitemid 44285960)